Correction of Gynecomastia in Bodybuilders: A case series of more than 5,000 patients treated over 33 years
Mordcai Blau, MD, and Ron Hazani, MD, share their experience in treating gynecomastia in bodybuilders in this clinical feature.
Mordcai Blau, MD, and Ron Hazani, MD, share their experience in treating gynecomastia in bodybuilders in this clinical feature.
A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches.